First New York Securities’s ResMed RMD Stock Holding History

First New York Securities’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-80,000	Closed	-$5.18M	–	177
2016 Q3	$5.18M	Buy	80,000 +14,210	+22%	+$946K	3.43%	9
2016 Q2	$4.16M	Buy	+65,790	New	+$3.88M	2.56%	9
2015 Q3	–	Sell	-100	Closed	-$5.64K	–	451
2015 Q2	$5.64K	Sell	100 -41,901	-100%	-$2.64M	﹤0.01%	352
2015 Q1	$3.01M	Buy	42,001 +42,000	+4,200,000%	+$2.73M	2.97%	7
2014 Q4	$56	Sell	1 -5,488	-100%	-$287K	﹤0.01%	335
2014 Q3	$270K	Buy	+5,489	New	+$280K	0.19%	99
2014 Q2	–	Sell	-6,000	Closed	-$268K	–	317
2014 Q1	$268K	Buy	6,000 +999	+20%	+$44.9K	0.13%	133
2013 Q4	$235K	Sell	5,001 -2,000	-29%	-$101K	0.14%	116
2013 Q3	$370K	Buy	+7,001	New	+$340K	0.15%	124

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Norges Bank Oslo, Norway $1T AUM

First New York Securities's RMD Position: Q4 2016 in Review

First New York Securities sold out of ResMed (RMD) in Q4 2016, closing a stake of 80,000 shares — an estimated $5.18M sold.

First New York Securities first reported a position in RMD in Q3 2013 and held it in 9 quarters. The position peaked at $5.18M in Q3 2016. 362 funds tracked by Wall St. Rank hold RMD as of Q4 2016.

First New York Securities reported no remaining ResMed position as of Q4 2016 after selling out during the quarter.
First New York Securities sold 80,000 ResMed shares in Q4 2016, an estimated $5.18M.
First New York Securities first reported a position in ResMed in Q3 2013 and held it in 9 quarters.
First New York Securities's ResMed position peaked at $5.18M in Q3 2016.
362 funds tracked by Wall St. Rank held ResMed as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.